看这个

临试 

https://clinicaltrials.gov/ct2/show/NCT03715114

https://ichgcp.net/clinical-trials-registry/NCT02293915

 

 

另几篇报道

https://www.biospace.com/article/releases/novel-drug-treatment-shows-improved-cognition-in-a-phase-3-clinical-trial-in-persons-with-mild-to-moderate-alzheimer-s-disease-in-china/ 

https://www.thepharmaletter.com/article/alzheimer-s-treatment-from-china-meets-phase-iii-goal

 

那个药

”GV-971 is a novel, marine-derived oligosaccharide, which has multi targeting mechanisms including inhibition of amyloid-β fibril formation, neuroinflammation, and recondition of dysbiosis of gut microbiota",

 

长期效果及副作用有待进一步评估